Estimate Recalculated Sep 13, 2024 10:29PM EST
James E. Levine does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cidara Therapeutics, Inc., Cardiff Oncology, Inc., and VERENIUM CORP.
James E. Levine's CIK is 0001463151
2021 was James E. Levine's most active year for acquiring shares with 7 total transactions. James E. Levine's most active month to acquire stocks was the month of August. 2013 was James E. Levine's most active year for disposing of shares, totalling 11 transactions. James E. Levine's most active month to dispose stocks was the month of September. 2009 saw James E. Levine paying a total of $82,400.00 for 361,666 shares, this is the most they've acquired in one year. In 2013 James E. Levine cashed out on 464,490 shares for a total of $436,664.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!